Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06560710
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-14
Brief Title:
Clinical Characteristics and Surgical Outcomes of Full-thickness Macular Hole Without Focal Vitreomacular Traction
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Clinical Characteristics and Surgical Outcomes of Full-thickness Macular Hole Without Focal Vitreomacular Traction
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This multicenter retrospective observational comparative study We occasionally encounter FTMHs in which PVD has not been achieved and VMT is absent These FTMHs cannot be defined by stage in the Gass1 or IVTS3 classification It is not known whether traction is involved in the development of these atypical macular holes but they are often classified as Gass stage 2 or 3 according to the size of the hole
The aim of this study was to investigate the clinical features and surgical outcomes of FTMHs without focal VMT and to discuss possible underlying mechanisms
The aim of this study was to investigate the clinical features and surgical outcomes of FTMHs without focal VMT and to discuss possible underlying mechanisms
Detailed Description:
The clinical characteristics and surgical outcomes the patients diagnosed with FTMH without focal VMT in the macula classified as VMT- are presented in addition to a comparative analysis of the patients presenting with classic stage 2 FTMH with focal VMT classified as VMT according to international classification criteria
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None